Company ProfilePremium

Meso Scale Diagnostics, LLC

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Meso Scale Diagnostics, LLC - Healthcare showcase

Year Founded & Workforce

1891

114,188 Employees

Industry

Healthcare

Services

Biomarker Services and Products
M

Meso Scale Diagnostics, LLC Employee Contacts

17 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Meso Scale Diagnostics, LLC Overview

Company Headquarters: Maryland, US

Founded: 1891

Workforce: ~114,188

Company Working:

Meso Scale Diagnostics, LLC develops, manufactures, and markets products and services for biological detection, measurement, and analysis. It offers V-PLEX immunoassays for the detection of biomarkers, such as IL-17A, IL-21, IL-22, IL-23, IL-27, and MIP-3a in human cell culture supernatants, serum, plasma, and urine. The company’s proprietary Multi Array technology enhances medical research and drug development by enabling researchers to profile many biomarkers simultaneously in a single sample without compromising assay performance. Meso Scale Discovery, a part of the company, offers a comprehensive set of services to screen, select, and validate custom biomarker tests.

Strategy

Meso Scale Diagnostics, LLC explores new possibilities to develop new products and expand its service offerings. The company aims to deliver unique outcomes to as many lives as possible. Also, it focuses on developing high-quality solutions and services by increasing its research and development capabilities.

Company Snapshot

114,188

Employees

1891

Founded

Maryland, US

Headquarters

SWOT Analysis

Strengths

  • Strong competency in service offerings
  • Participates in various government seminars showcasing its flagship products

Weaknesses

  • Gaps in the product range sold by the company

Opportunities

  • Expansion of distribution channels

Threats

  • New technologies developed by competitors

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
February 2017Product LaunchMeso Scale Discovery, a division of Meso Scale Diagnostics, LLC, launched V-PLEX immunoassays validated for the detection of the biomarkers IL-17A, IL-21, IL-22, IL-23, IL-27, and MIP-3α in human cell culture supernatants, serum, plasma, and urine.

Product Offering

  • Meso Scale Diagnostics, LLC
    • Biomarker Services and Products

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.